89 related articles for article (PubMed ID: 6574806)
1. Histocompatibility testing in patients with carcinoma of the bladder.
Lytton B; O'Toole C; Tiptaft R; Festenstein H; Batchelor JR
Cancer; 1983 Aug; 52(4):645-7. PubMed ID: 6574806
[TBL] [Abstract][Full Text] [Related]
2. HLA-A, B and DR in Caucasians with transitional cell carcinoma of the bladder.
Saunders PH; Anderson SA; Stogdill VD; Lamm DL
Tissue Antigens; 1983 Nov; 22(5):389-92. PubMed ID: 6581580
[TBL] [Abstract][Full Text] [Related]
3. Association between HLA antigens and bladder tumors.
Tokuç R; Akdaş A; Ozerkan K; Remzi D
Eur Urol; 1987; 13(3):207-9. PubMed ID: 3497040
[TBL] [Abstract][Full Text] [Related]
4. Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival.
Levin I; Klein T; Goldstein J; Kuperman O; Kanetti J; Klein B
Cancer; 1991 Dec; 68(12):2591-4. PubMed ID: 1933807
[TBL] [Abstract][Full Text] [Related]
5. HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder.
Braf ZF; Gazit E; Many M
J Urol; 1979 Oct; 122(4):465-6. PubMed ID: 480486
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens and transitional cell carcinoma of the bladder.
Eryiğit M; Kirkali Z
Urol Int; 1990; 45(2):75-7. PubMed ID: 2330661
[TBL] [Abstract][Full Text] [Related]
7. HL-A antigens and transitional-cell carcinoma of the bladder.
Arce S; López R; Almaguer M; Ballester JM; Filgueiras E; Ustariz C; Pérez S; Hernández E
Mater Med Pol; 1978; 10(2):98-100. PubMed ID: 81357
[No Abstract] [Full Text] [Related]
8. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
9. Association between HLA-A, B, C and DR antigens and clinical manifestations of Schistosoma haematobium in the bladder.
Wishahi M; el-Baz HG; Shaker ZA
Eur Urol; 1989; 16(2):138-43. PubMed ID: 2497017
[TBL] [Abstract][Full Text] [Related]
10. Malignant bone and soft-tissue tumor and HLA.
Wong AC
Nihon Seikeigeka Gakkai Zasshi; 1985 Jul; 59(7):719-33. PubMed ID: 3864905
[TBL] [Abstract][Full Text] [Related]
11. Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma.
Tomita Y; Matsumoto Y; Nishiyama T; Fujiwara M
J Pathol; 1990 Oct; 162(2):157-64. PubMed ID: 2250194
[TBL] [Abstract][Full Text] [Related]
12. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
13. Genetic association with bladder cancer.
Br Med J; 1979 Sep; 2(6189):514. PubMed ID: 497668
[No Abstract] [Full Text] [Related]
14. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.
Gan LH; Huang LF; Zhang X; Lin A; Xu DP; Wang Q; Wang TJ; Yan WH
Hum Immunol; 2010 Sep; 71(9):899-904. PubMed ID: 20600448
[TBL] [Abstract][Full Text] [Related]
15. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population.
Castelli EC; Mendes-Junior CT; Viana de Camargo JL; Donadi EA
Tissue Antigens; 2008 Aug; 72(2):149-57. PubMed ID: 18721275
[TBL] [Abstract][Full Text] [Related]
16. HLA-D antigens in a Czech population and their association with HLA-DR antigens.
Hinzová E; Ivasková E; Cukrová V; Rychlíková M
Folia Biol (Praha); 1980; 26(4):267-74. PubMed ID: 6773825
[TBL] [Abstract][Full Text] [Related]
17. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
Darke C; Wagner MM; Nuki G; Dyer PA
Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
[TBL] [Abstract][Full Text] [Related]
18. [HL-A antigenicity in bladder tumors].
Jakse G; Hofstädter F
Helv Chir Acta; 1978 Jul; 45(3):313-6. PubMed ID: 701068
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
Malmström PU
Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
[TBL] [Abstract][Full Text] [Related]
20. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis.
Armstrong RD; Panayi GS; Welsh KI
Ann Rheum Dis; 1983 Apr; 42(2):142-6. PubMed ID: 6573872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
